{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:06:05Z","timestamp":1738991165467,"version":"3.37.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00787-024-02565-w","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T14:04:51Z","timestamp":1726149891000},"page":"361-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should methylphenidate be included in the WHO model lists of essential medicines?"],"prefix":"10.1007","volume":"34","author":[{"given":"Johanne Pereira","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja Rosenberg Overby","family":"Storm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Jakob","family":"Storeb\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"5","key":"2565_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00787-024-02443-5","volume":"33","author":"S Cortese","year":"2024","unstructured":"Cortese S, Coghill D, Fegert JM, Mattingly GW, Rohde LA, Wong ICK, Faraone SV (2024) ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines. Eur Child Adolesc Psychiatry 33(5):1605\u20131608. https:\/\/doi.org\/10.1007\/s00787-024-02443-5","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2565_CR2","doi-asserted-by":"publisher","unstructured":"Pereira Ribeiro J, Lunde C, Gluud C, Simonsen E, Storeb\u00f8 OJ (2022) Methylphenidate denied access to the WHO List of Essential Medicines for the second time. BMJ Evidence-Based Medicine. Advance online publication. https:\/\/doi.org\/10.1136\/bmjebm-2021-111862","DOI":"10.1136\/bmjebm-2021-111862"},{"issue":"4","key":"2565_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bmjebm-2019-111328","volume":"26","author":"OJ Storeb\u00f8","year":"2021","unstructured":"Storeb\u00f8 OJ, Gluud C (2021) Methylphenidate for ADHD rejected from the WHO essential Medicines List due to uncertainties in benefit-harm profile. BMJ Evidence-Based Med 26(4):172\u2013175. https:\/\/doi.org\/10.1136\/bmjebm-2019-111328","journal-title":"BMJ Evidence-Based Med"},{"key":"2565_CR4","unstructured":"World Health Organization, WHO Expert Committee on Selection and Use of Essential Medicines (2021) The selection and use of essential medicines: Report of the, 2021 (including the 22nd WHO Model List of Essential Medicines and the 8th WHO Model List of Essential Medicines for Children). World Health Organization. www.who.int\/publications\/i\/item\/9789240041134"},{"key":"2565_CR5","unstructured":"World Health Organization (2021b) Decision on methylphenidate: https:\/\/list.essentialmeds.org\/recommendations\/1200"},{"issue":"5","key":"2565_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2215-0366(23)00042-1","volume":"10","author":"KKC Man","year":"2023","unstructured":"Man KKC, H\u00e4ge A, Banaschewski T, Inglis SK, Buitelaar J, Carucci S, Danckaerts M et al (2023) Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the attention deficit hyperactivity disorder drugs use Chronic effects (ADDUCE) study. Lancet Psychiatry 10(5):323\u2013333. https:\/\/doi.org\/10.1016\/S2215-0366(23)00042-1","journal-title":"Lancet Psychiatry"},{"key":"2565_CR7","doi-asserted-by":"publisher","unstructured":"Storeb\u00f8 OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira\u2010Maia CR et al (2018) Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents \u2013 assessment of adverse events in non\u2010randomised studies. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD012069. https:\/\/doi.org\/10.1002\/14651858.CD012069.pub2","DOI":"10.1002\/14651858.CD012069.pub2"},{"issue":"3","key":"2565_CR8","doi-asserted-by":"publisher","first-page":"CD009885","DOI":"10.1002\/14651858.CD009885.pub3","volume":"3","author":"OJ Storeb\u00f8","year":"2023","unstructured":"Storeb\u00f8 OJ, Storm MRO, Pereira Ribeiro J, Skoog M, Groth C, Callesen HE, Schaug JP et al (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Reviews 3(3):CD009885. https:\/\/doi.org\/10.1002\/14651858.CD009885.pub3","journal-title":"Cochrane Database Syst Reviews"},{"key":"2565_CR9","doi-asserted-by":"publisher","unstructured":"Storeb\u00f8 OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD et al (2015) Methylphenidate for attention-deficit\/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ 351:h5203. https:\/\/doi.org\/10.1136\/bmj.h5203","DOI":"10.1136\/bmj.h5203"},{"issue":"10","key":"2565_CR10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00134-018-5293-7","volume":"44","author":"A Lundh","year":"2018","unstructured":"Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L (2018) Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Med 44(10):1603\u20131612. https:\/\/doi.org\/10.1007\/s00134-018-5293-7","journal-title":"Intensive Care Med"},{"key":"2565_CR11","volume-title":"Programme (mhGAP) guideline for mental, neurological and substance use disorders","author":"Mental Health Gap Action","year":"2023","unstructured":"Mental Health Gap Action (2023) Programme (mhGAP) guideline for mental, neurological and substance use disorders. World Health Organization, Geneva. Licence: CC BY-NC-SA 3.0 IGO"},{"key":"2565_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/14034948231219826","author":"TA Kolari","year":"2024","unstructured":"Kolari TA, Vuori M, R\u00e4tt\u00f6 H, Varimo EA, Aronen ET, Saastamoinen LK, Ruokoniemi PT (2024) Incidence of ADHD medication use among Finnish children and adolescents in 2008\u20132019: a need for practice changes? Scandinavian J Public Health Adv Online Publication. https:\/\/doi.org\/10.1177\/14034948231219826","journal-title":"Scandinavian J Public Health Adv Online Publication"},{"issue":"10","key":"2565_CR13","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1097\/MS9.0000000000001179","volume":"85","author":"G Olatunji","year":"2023","unstructured":"Olatunji G, Faturoti O, Jaiyeoba B, Toluwabori A, Adefusi T, Olaniyi P, Aderinto N, Abdulbasit M (2023) Navigating unique challenges and advancing equitable care for children with ADHD in Africa: a review. Annals Med Surg 85(10):4939\u20134946. https:\/\/doi.org\/10.1097\/MS9.0000000000001179","journal-title":"Annals Med Surg"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-024-02565-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:32:58Z","timestamp":1738902778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-024-02565-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2565"],"URL":"https:\/\/doi.org\/10.1007\/s00787-024-02565-w","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"type":"print","value":"1018-8827"},{"type":"electronic","value":"1435-165X"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}